[Preliminary results of prophylactic adjuvant chemotherapy with CISCA in bladder tumors].
Over a period of 7 years, 14 patients with cancer of the bladder received postoperative curative adjunct chemotherapy with the CISCA protocol. Follow-up ranges from 5 to 84 months. Eleven patients had complete remission, 1 had a recurrence and 2 died. The results encourage us to administer systemic adjunct chemotherapy, whenever there are histologically-proven neoplastic emboli to the lymphatics.
Bittard
H
H
Service d'Urologie, CHU Besançon.
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D011379:Prognosis; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000601:surgery
D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin
Résultats préliminaires de la chimiothérapie adjuvante prophylactique par CISCA dans les tumeurs de vessie.